ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Merck will boost production in Ireland

by Rick Mullin
June 5, 2017 | APPEARED IN VOLUME 95, ISSUE 23

Merck & Co. will spend $315 million over the next three years to boost drug and vaccine production at facilities in Counties Carlow and Cork, Ireland. The investment is expected to create 200 jobs at the Cork plant. There, Merck specializes in fermentation, purification, and sterilization of biologic medicines for lung cancer, melanoma, hepatitis C, and arthritis. The Carlow facility, which makes vaccines and biologics, will take on 120 new employees.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment